Cannabinoid Discrimination
Cannabinoid Discrimination is a drug discrimination paradigm in behavioral pharmacology wherein subjects are trained to recognize the interoceptive effects of cannabinoid agonists, thereby enabling the study of cannabinoid receptor activation and its role in perceptual and behavioral specificity.
113
Publications
4.7K
Citations
291
Authors
96
Institutions
Publications per year
2017–2026
16
Parents
113
Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats
Jenny L. Wiley, R.L. Barrett, John Lowe et al. · Neuropharmacology · 1995 · 122 citations
Medicine, Neuroscience, Pharmacology +11
1–5 of 113
291
15
h-index
13
h-index
8
h-index
Virginia Commonwealth University Medical Center, United States
8 publications · 423 citations
8
h-index
The University of Texas at San Antonio Health Science Center, United States
8 publications · 317 citations
8
h-index
1–5 of 291
96

The University of Texas at San Antonio Health Science Center
San Antonio, United States
12 h-index
23 publications
1K citations

Virginia Commonwealth University Medical Center
Richmond, United States
9 h-index
27 publications
1.1K citations

Uppsala University
Uppsala, Sweden
9 h-index
21 publications
649 citations
Northeastern University
Boston, United States
9 h-index
48 publications
1.4K citations
Virginia Commonwealth University
Richmond, United States
6 h-index
33 publications
1.5K citations
RTI International
Durham, United States
6 h-index
14 publications
517 citations
Temple University
Philadelphia, United States
6 h-index
8 publications
221 citations
National Institute on Drug Abuse
Bethesda, United States
5 h-index
10 publications
802 citations
1–8 of 96
26 publications · 1.1K citations
22
h-index
12 publications · 397 citations
12
h-index
13 publications · 622 citations
12
h-index
8 publications · 253 citations
8
h-index
7 publications · 330 citations
7
h-index
1–5